Skip to main content
Top
Published in: Clinical and Experimental Nephrology 3/2014

01-06-2014 | Original Article

Prevalence and risk factor analysis of nephrosclerosis and ischemic nephropathy in the Japanese general population

Authors: Naoki Shiraishi, Kenichiro Kitamura, Yukimasa Kohda, Kunitoshi Iseki, Kimio Tomita

Published in: Clinical and Experimental Nephrology | Issue 3/2014

Login to get access

Abstract

Background

Nephrosclerosis/ischemic nephropathy (NS/IN) ranks third among renal diseases requiring dialysis in Japan. Although it is an important renal disease in terms of frequency, its prevalence, new incidence, and risk factors are not fully elucidated.

Methods

We analyzed the prevalence, incidence, concurrent diseases, and risk factors of NS/IN by using data from specific health checkups of Kumamoto citizens between 2008 and 2010.

Results

Although the prevalence of NS/IN was 1−2 % in people in their 40s, it increased sharply with age, reaching 17.6 % in people aged 70–74 years. The incidence of new NS/IN was 0.4−0.5 % per year. In multivariate logistic regression analysis, factors such as age, male gender, body mass index (BMI), hyperuricemia, hypertension, and dyslipidemia correlated with NS/IN. When risk factors associated with NS/IN progress were evaluated by multivariate logistic regression analysis, four factors—male gender, hypertension, BMI, and current smoking—significantly correlated.

Conclusion

The analysis of Kumamoto citizens aged 40–74 years receiving specific health checkups showed that in addition to hypertension and age that were considered important, male gender and obesity are also risk factors for NS/IS independent from hypertension.
Literature
1.
go back to reference Szwed JJ. Urinalysis and clinical renal disease. Am J Med Technol. 1980;46:720–5.PubMed Szwed JJ. Urinalysis and clinical renal disease. Am J Med Technol. 1980;46:720–5.PubMed
2.
go back to reference Takebayashi S, Kiyoshi Y, Hisano S, Uesugi N, Sasatomi Y, Meng J, Sakata N. Benign nephrosclerosis: incidence, morphology and prognosis. Clin Nephrol. 2001;55:349–56.PubMed Takebayashi S, Kiyoshi Y, Hisano S, Uesugi N, Sasatomi Y, Meng J, Sakata N. Benign nephrosclerosis: incidence, morphology and prognosis. Clin Nephrol. 2001;55:349–56.PubMed
3.
4.
go back to reference Zucchelli P, Zuccalà A. Recent data on hypertension and progressive renal disease. J Hum Hypertens. 1996;10:679–82.PubMed Zucchelli P, Zuccalà A. Recent data on hypertension and progressive renal disease. J Hum Hypertens. 1996;10:679–82.PubMed
5.
go back to reference The Committee of Japanese Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc. 2010;53:450–67. The Committee of Japanese Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc. 2010;53:450–67.
6.
go back to reference Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Definition and the diagnostic standard for metabolic syndrome. Nippon Naika Gakkai Zasshi. 2005;94:794–809.CrossRef Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Definition and the diagnostic standard for metabolic syndrome. Nippon Naika Gakkai Zasshi. 2005;94:794–809.CrossRef
7.
go back to reference Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A. Revised equations for estimated GFR from serum creatinine in Japan; Collaborators developing the Japanese equation for estimated GFR. Am J Kidney Dis. 2009;53:982–92.PubMedCrossRef Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A. Revised equations for estimated GFR from serum creatinine in Japan; Collaborators developing the Japanese equation for estimated GFR. Am J Kidney Dis. 2009;53:982–92.PubMedCrossRef
8.
go back to reference Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, Ura N, Kiyohara Y, Moriyama T, Ando Y, Fujimoto S, Konta T, Yokoyama H, Makino H, Hishida A, Matsuo S. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13:621–30.PubMedCrossRef Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, Ura N, Kiyohara Y, Moriyama T, Ando Y, Fujimoto S, Konta T, Yokoyama H, Makino H, Hishida A, Matsuo S. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13:621–30.PubMedCrossRef
9.
go back to reference Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88:2404–11.PubMedCrossRef Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88:2404–11.PubMedCrossRef
10.
go back to reference Diez Ojea B, Marín R, Coto E, Fernández Vega F, Alvarez Navascués R, Fernández Fresnedo G, Pobes Martínez de Salinas A, Suárez Laurés A, García Monteavaro C, Gorostidi M, Sánchez E, Arias M, Ortega F. Clinical and genetic basis of hypertensive nephrosclerosis. NEFROSEN study. Nefrologia. 2010;30:687–97.PubMed Diez Ojea B, Marín R, Coto E, Fernández Vega F, Alvarez Navascués R, Fernández Fresnedo G, Pobes Martínez de Salinas A, Suárez Laurés A, García Monteavaro C, Gorostidi M, Sánchez E, Arias M, Ortega F. Clinical and genetic basis of hypertensive nephrosclerosis. NEFROSEN study. Nefrologia. 2010;30:687–97.PubMed
11.
go back to reference Kalaitzidis RG, Siamopoulos KC. The role of obesity in kidney disease: recent findings and potential mechanisms. Int Urol Nephrol. 2011;43:771–84.PubMedCrossRef Kalaitzidis RG, Siamopoulos KC. The role of obesity in kidney disease: recent findings and potential mechanisms. Int Urol Nephrol. 2011;43:771–84.PubMedCrossRef
12.
go back to reference Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis. 2004;44:642–50.PubMedCrossRef Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis. 2004;44:642–50.PubMedCrossRef
13.
go back to reference Samuelsson O, Mulec H, Knight-Gibson C, Attman PO, Kron B, Larsson R, Weiss L, Wedel H, Alaupovic P. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant. 1997;12:1908–15.PubMedCrossRef Samuelsson O, Mulec H, Knight-Gibson C, Attman PO, Kron B, Larsson R, Weiss L, Wedel H, Alaupovic P. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant. 1997;12:1908–15.PubMedCrossRef
14.
go back to reference Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, Narita M, Koyama A. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71:159–66.PubMedCrossRef Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, Narita M, Koyama A. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71:159–66.PubMedCrossRef
15.
go back to reference Noborisaka Y, Ishizaki M, Yamada Y. Paradoxical signs of smoking-induced chronic kidney disease (CKD) in generally healthy populations, especially those from workplaces. J Kanazawa Med Univ. 2011;36:98–105. Noborisaka Y, Ishizaki M, Yamada Y. Paradoxical signs of smoking-induced chronic kidney disease (CKD) in generally healthy populations, especially those from workplaces. J Kanazawa Med Univ. 2011;36:98–105.
16.
go back to reference Marín R, Gorostidi M, Fernández-Vega F, Alvarez-Navascués R. Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis. Kidney Int Suppl. 2005:S52–56. Marín R, Gorostidi M, Fernández-Vega F, Alvarez-Navascués R. Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis. Kidney Int Suppl. 2005:S52–56.
17.
go back to reference Tomson CR, Petersen K, Heagerty AM. Does treated essential hypertension result in renal impairment? A cohort study. J Hum Hypertens. 1991;5:189–92.PubMed Tomson CR, Petersen K, Heagerty AM. Does treated essential hypertension result in renal impairment? A cohort study. J Hum Hypertens. 1991;5:189–92.PubMed
18.
go back to reference Hsu CY. Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials. J Hum Hypertens. 2001;15:99–106.PubMedCrossRef Hsu CY. Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials. J Hum Hypertens. 2001;15:99–106.PubMedCrossRef
Metadata
Title
Prevalence and risk factor analysis of nephrosclerosis and ischemic nephropathy in the Japanese general population
Authors
Naoki Shiraishi
Kenichiro Kitamura
Yukimasa Kohda
Kunitoshi Iseki
Kimio Tomita
Publication date
01-06-2014
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 3/2014
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-013-0833-5

Other articles of this Issue 3/2014

Clinical and Experimental Nephrology 3/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.